scholarly article | Q13442814 |
P356 | DOI | 10.1002/ART.39417 |
P698 | PubMed publication ID | 26360137 |
P50 | author | Jurjen Tel | Q38589617 |
Johan Van Der Vlag | Q43142256 | ||
Jolanda de Vries | Q64030559 | ||
P2093 | author name string | Jaap Fransen | |
Luuk B Hilbrands | |||
Jo H Berden | |||
Nils Rother | |||
Marinka Bakker | |||
Jürgen Dieker | |||
Henry B P M Dijkman | |||
Elmar Pieterse | |||
Astrid Thielen | |||
P433 | issue | 2 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
dendritic cell | Q506253 | ||
apoptotic process | Q14599311 | ||
P304 | page(s) | 462-472 | |
P577 | publication date | 2016-02-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis | |
P478 | volume | 68 |
Q37742466 | A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus. |
Q41673025 | Acetylated Histones in Apoptotic Microparticles Drive the Formation of Neutrophil Extracellular Traps in Active Lupus Nephritis. |
Q89266529 | Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus |
Q92503806 | Apoptotic cell-derived exosomes: messages from dying cells |
Q88671353 | Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans |
Q36174201 | Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis. |
Q99248292 | Autoantibody-dependent amplification of inflammation in SLE |
Q92239639 | CD4+CD25+LAG3+ T Cells With a Feature of Th17 Cells Associated With Systemic Lupus Erythematosus Disease Activity |
Q38926368 | Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis |
Q89931774 | Chicken-or-egg question: Which came first, extracellular vesicles or autoimmune diseases? |
Q92581798 | Classical dendritic cells regulate acute lung inflammation and injury in mice with lipopolysaccharide‑induced acute respiratory distress syndrome |
Q58620990 | DNA as a self-antigen: nature and regulation |
Q60959930 | Differential Interaction of Platelet-Derived Extracellular Vesicles With Circulating Immune Cells: Roles of TAM Receptors, CD11b, and Phosphatidylserine |
Q37272155 | Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity |
Q33820385 | Distinct proteome pathology of circulating microparticles in systemic lupus erythematosus |
Q26773124 | Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus |
Q52324051 | Elevated extracellular nucleosomes and their relevance to inflammation in stage 5 chronic kidney disease. |
Q39169139 | Expanding the B Cell-Centric View of Systemic Lupus Erythematosus |
Q92860794 | Extracellular DNA traps in inflammation, injury and healing |
Q33624336 | Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus |
Q52680357 | From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders. |
Q90225438 | Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11chiCD11b+ Dendritic Cells in NZB/W F1 Mice |
Q92591894 | Increased salivary microvesicles are associated with the prognosis of patients with oral squamous cell carcinoma |
Q64113375 | Innate Immune Cells' Contribution to Systemic Lupus Erythematosus |
Q40514474 | Innate and humoral recognition of the products of cell death: differential antigenicity and immunogenicity in lupus |
Q55178431 | Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus. |
Q57177158 | Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6 |
Q95592748 | Lupus nephritis |
Q90568852 | Microparticles from Endothelial Cells and Immune Cells in Patients with Takayasu Arteritis |
Q42682355 | Microparticles from patients with systemic lupus erythematosus induce production of reactive oxygen species and degranulation of polymorphonuclear leukocytes |
Q37363894 | Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations |
Q37633711 | Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage |
Q38998709 | NETopathies? Unraveling the Dark Side of Old Diseases through Neutrophils |
Q39170198 | Neutrophils Discriminate between Lipopolysaccharides of Different Bacterial Sources and Selectively Release Neutrophil Extracellular Traps. |
Q39016144 | New insights into the immunopathogenesis of systemic lupus erythematosus. |
Q54116627 | PKM2 Is Required to Activate Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia. |
Q55331760 | Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus. |
Q92222878 | Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus |
Q48109327 | Recent advances in pathophysiology of disseminated intravascular coagulation: the role of circulating histones and neutrophil extracellular traps |
Q33806541 | Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis. |
Q36737940 | Regulation of chronic inflammatory and immune processes by extracellular vesicles |
Q92239589 | Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects |
Q52668322 | The Neutrophil's Choice: Phagocytose vs Make Neutrophil Extracellular Traps. |
Q92956352 | The Role of NETosis in Systemic Lupus Erythematosus |
Q36127922 | The Use of Poly-L-Lysine as a Capture Agent to Enhance the Detection of Antinuclear Antibodies by ELISA. |
Q90737847 | Therapeutic potential of aryl hydrocarbon receptor in autoimmunity |
Search more.